418 related articles for article (PubMed ID: 26640901)
1. Implications of Treating Hepatitis C Virus Infection Among Patients Awaiting Cadaveric Liver Transplant: A Single-Center Experience.
Ofosu A; Durand CM; Saberi B; Alqahtani S; Ucbilek E; Belden M; Cameron AM; Gurakar A
Exp Clin Transplant; 2015 Nov; 13 Suppl 3():7-10. PubMed ID: 26640901
[TBL] [Abstract][Full Text] [Related]
2. Pre- Versus Posttransplant Treatment of Hepatitis C Virus With Direct-Acting Antivirals in Liver Transplant Recipients: More Issues to be Solved.
Abdelqader A; Kabacam G; Woreta TA; Hamilton JP; Luu H; Al Khalloufi K; Saberi B; Philosophe B; Cameron AM; Gurakar A
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):1-5. PubMed ID: 28260422
[TBL] [Abstract][Full Text] [Related]
3. Liver Transplant From Increased-Risk Donors in the Era of Direct-Acting Antivirals for Hepatitis C.
Shaikh OS; Rogal S; Malik A; Sharma V; Cacciarelli T
Exp Clin Transplant; 2020 Oct; 18(5):605-611. PubMed ID: 31324136
[TBL] [Abstract][Full Text] [Related]
4. Liver transplantation from anti-hepatitis C virus-positive donors: our experience.
Álvaro E; Abradelo M; Fuertes A; Manrique A; Colina F; Alegre C; Calvo J; García M; García-Sesma A; Cambra F; Sanabria R; Moreno E; Jimenez C
Transplant Proc; 2012; 44(6):1475-8. PubMed ID: 22841188
[TBL] [Abstract][Full Text] [Related]
5. Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years.
Nafady-Hego H; Elgendy H; Nafady A; Uemoto S
Exp Clin Transplant; 2016 Apr; 14(2):207-14. PubMed ID: 26867537
[TBL] [Abstract][Full Text] [Related]
6. Timing of Hepatitis C Antiviral Therapy in Liver Transplant Recipients With Direct-acting Agents.
Suraweera D; Saab EG; Tong MJ; Saab S
Exp Clin Transplant; 2016 Jun; 14(3):243-51. PubMed ID: 27221717
[TBL] [Abstract][Full Text] [Related]
7. Lessons Learned From Review of a Single Center Experience With 500 Consecutive Liver Transplants in a Region With Insufficient Deceased-Donor Support.
Yankol Y; Mecit N; Kanmaz T; Cimsit B; Cakaloglu Y; Acarli K; Kalayoglu M
Exp Clin Transplant; 2016 Apr; 14(2):191-200. PubMed ID: 26030810
[TBL] [Abstract][Full Text] [Related]
8. Utilization of hepatitis C virus RNA-positive donor liver for transplant to hepatitis C virus RNA-negative recipient.
Saberi B; Hamilton JP; Durand CM; Li Z; Philosophe B; Cameron AM; Sulkowski MS; Gurakar A
Liver Transpl; 2018 Jan; 24(1):140-143. PubMed ID: 28779557
[No Abstract] [Full Text] [Related]
9. Prophylaxis Among Hepatitis B Core Antibody-positive Deceased-donor Liver Transplant Recipients: Hepatitis B Immunoglobulin Plus Oral Antiviral Agents Versus Antiviral Agents Alone: A Single-center Experience.
Malik MU; Ucbilek E; Trilianos P; Cameron AM; Gurakar A
Exp Clin Transplant; 2017 Apr; 15(2):183-188. PubMed ID: 27212251
[TBL] [Abstract][Full Text] [Related]
10. Should organs from hepatitis C-positive donors be used in hepatitis C-negative recipients for liver transplantation?
Selzner N; Berenguer M
Liver Transpl; 2018 Jun; 24(6):831-840. PubMed ID: 29624894
[TBL] [Abstract][Full Text] [Related]
11. Improved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct-Acting Antiviral Era.
Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
Liver Transpl; 2019 Apr; 25(4):598-609. PubMed ID: 30716208
[TBL] [Abstract][Full Text] [Related]
12. Shear-wave elastography for the assessment of liver fibrosis in liver transplant recipients treated for hepatitis C virus recurrence.
Korda D; Lenard ZM; Gerlei Z; Jakab Z; Haboub-Sandil A; Wagner L; Varga M; Cseprekal O; Marton A; Horvathy D; Takacs S; Doros A; Mathe Z
Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):27-32. PubMed ID: 29049126
[TBL] [Abstract][Full Text] [Related]
13. The New Era of Hepatitis C: Therapy in Liver Transplant Recipients.
Little EC; Berenguer M
Clin Liver Dis; 2017 May; 21(2):421-434. PubMed ID: 28364822
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C-positive donor liver transplantation for hepatitis C seronegative recipients.
Ting PS; Hamilton JP; Gurakar A; Urrunaga NH; Ma M; Glorioso J; King E; Toman LP; Wesson R; Garonzik-Wang J; Ottmann S; Philosophe B; Sulkowski M; Cameron AM; Durand CM; Chen PH
Transpl Infect Dis; 2019 Dec; 21(6):e13194. PubMed ID: 31609520
[TBL] [Abstract][Full Text] [Related]
15. Interferon-Free Therapy for Hepatitis C in Liver Transplant Recipients.
Ueda Y; Uemoto S
Transplantation; 2016 Jan; 100(1):54-60. PubMed ID: 26335914
[TBL] [Abstract][Full Text] [Related]
16. Use of Organs From Hepatitis C Virus-Positive Donors for Uninfected Recipients: A Potential Cost-Effective Approach to Save Lives?
Trotter PB; Summers DM; Ushiro-Lumb I; Robb M; Bradley JA; Powell J; Watson CJE; Neuberger J
Transplantation; 2018 Apr; 102(4):664-672. PubMed ID: 29166338
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis viruses and liver transplantation: evolving trends in antiviral management.
Verna EC
Clin Liver Dis; 2014 Aug; 18(3):575-601. PubMed ID: 25017077
[TBL] [Abstract][Full Text] [Related]
18. Transplantation of kidneys from hepatitis C-positive donors into hepatitis C virus-infected recipients followed by early initiation of direct acting antiviral therapy: a single-center retrospective study.
Bhamidimarri KR; Ladino M; Pedraza F; Guerra G; Mattiazzi A; Chen L; Ciancio G; Kupin W; Martin P; Burke G; Roth D
Transpl Int; 2017 Sep; 30(9):865-873. PubMed ID: 28332729
[TBL] [Abstract][Full Text] [Related]
19. Management of recurrent hepatitis C virus after liver transplantation.
Jiménez-Pérez M; González-Grande R; Rando-Muñoz FJ
World J Gastroenterol; 2014 Nov; 20(44):16409-17. PubMed ID: 25469009
[TBL] [Abstract][Full Text] [Related]
20. Liver Transplant Outcomes in a Newly Started Program.
Sultanaliev T; Zhexembayev A; Mukazhanov A; Zharkymbekov B; Kuttymuratov G; Spatayev Z; Ibrayev B; Yesmembetov K; Ashimkhanova A; Asykbayev M
Exp Clin Transplant; 2015 Nov; 13 Suppl 3():120-2. PubMed ID: 26640930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]